Concepedia

Brandon Carter‐Cooper

BC

Statistics

Publications

16

Citations

465

H-Index

15

Active since

2012

Affiliations

University of Maryland, Baltimore(Current)

U-M Rogel Cancer Center

University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center

Purdue University West Lafayette

University of Maryland, College Park

Brandon Carter‐Cooper is an author at University of Maryland, Baltimore specializing in medicine, oncology, and molecular oncology.

Publications per year

2012–2022

16

Publications

16

Presence of isocitrate dehydrogenase mutations may predict clinical response to hypomethylating agents in patients with acute myeloid leukemia

Ashkan Emadi, Rawan Faramand, Brandon Carter‐Cooper et al. · American Journal of Hematology · 2015 · 75 citations · Full text

Medicine, Genetics, Oncology +14

Asparaginase Erwinia chrysanthemi effectively depletes plasma glutamine in adult patients with relapsed/refractory acute myeloid leukemia

Ashkan Emadi, Jennie Y. Law, Erin T. Strovel et al. · Cancer Chemotherapy and Pharmacology · 2017 · 53 citations

Medicine, Oncology, Pharmacology +10

Regulation of cisplatin-resistant head and neck squamous cell carcinoma by the SRC/ETS-1 signaling pathway

Zejia Yang, Jipei Liao, Brandon Carter‐Cooper et al. · BMC Cancer · 2019 · 41 citations · Full text

Medicine, Cancer Biology, Molecular Biology +15

Baseline extracellular vesicle TGF‐β is a predictive biomarker for response to immune checkpoint inhibitors and survival in non–small cell lung cancer

Diego de Miguel‐Pérez, Alessandro Russo, Muthukumar Gunasekaran et al. · Cancer · 2022 · 40 citations · Full text

Medicine, Immunology, Oncology +17

Venetoclax and pegcrisantaspase for complex karyotype acute myeloid leukemia

Ashkan Emadi, Bandish Kapadia, Dominique Bollino et al. · Leukemia · 2020 · 36 citations · Full text

Medicine, Hematology, Oncology +6

1–5 of 16